NEOGENOMICS INC Operating Income Loss

• NEOGENOMICS INC showed a decrease of -25.8% in Operating Income Loss from 2024 to 2025.
• This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), NEOGENOMICS INC's Operating Income Loss has declined by 3,810.9%.
• Historical annual values: Fiscal year 2025: -$115.88 million | Fiscal year 2024: -$92.11 million | Fiscal year 2023: -$107.74 million | Fiscal year 2022: -$157.62 million | Fiscal year 2021: -$118.75 million | Fiscal year 2020: -$13.99 million | Fiscal year 2019: $13.01 million | Fiscal year 2018: $10.04 million | Fiscal year 2017: $2.90 million | Fiscal year 2016: $2.16 million | Fiscal year 2015: -$5.64 million | Fiscal year 2014: $2.22 million | Fiscal year 2013: $3.17 million | Fiscal year 2012: $1.21 million | Fiscal year 2011: -$409.0 thousand | Fiscal year 2010: -$2.96 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026